Cost‐Effectiveness of Dimethyl Fumarate Versus Teriflunomide in Patients With Relapsing‐Remitting Multiple Sclerosis (RRMS) in Iran

ABSTRACT Background and Aims Multiple sclerosis (MS) is an autoimmune disorder that damages the myelin sheath on nerve fibers in the central nervous system, leading to axonal damage and neuron death. This study aimed to assess the cost‐effectiveness of dimethyl fumarate compared with teriflunomide a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Maryam Poursadeghfard, Yasin Farjah, Mehdi Rezaee, Nastaran Momtahan, Mohammad Hossein Morowvat, Ahmad Gholami, Khosro Keshavarz
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-04-01
Col·lecció:	Health Science Reports
Matèries:	dimethyl fumarate economic evaluation multiple sclerosis QALY teriflunomide
Accés en línia:	https://doi.org/10.1002/hsr2.72089
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!